ARCTURUS THERAPEUTICS HOLDINGS INC.

(ARCT)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector news
Communiqués de presse de la société ARCTURUS THERAPEUTICS HOLDINGS INC.
05/09ARCTURUS THERAPEUTICS HOLDINGS INC. Management's Discussion and Analysis of Financial ..
AQ
05/09ARCTURUS THERAPEUTICS : Q1 Earnings Snapshot
AQ
05/09Arcturus Therapeutics Announces First Quarter 2022 Financial Update and Pipeline Progre..
BU
05/05CORRECTING and REPLACING GRAPHIC Arcturus Reports Strong Three-Month Durability Results..
BU
04/27Arcturus Therapeutics to Report First Quarter 2022 Financial Results and Provide Corpor..
BU
04/22Arcturus Therapeutics Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
BU
04/20ARCTURUS THERAPEUTICS : Announces Self-amplifying COVID-19 mRNA Vaccine Candidate ARCT-154..
PU
04/20ARCTURUS THERAPEUTICS HOLDINGS INC. : Entry into a Material Definitive Agreement, Terminat..
AQ
04/20Arcturus Announces Self-amplifying COVID-19 mRNA Vaccine Candidate ARCT-154 Meets Prima..
BU
03/28Arcturus Therapeutics to Participate in the Cantor Fitzgerald Virtual Rare Orphan Disea..
AQ
03/25Arcturus Therapeutics to Participate in the Cantor Fitzgerald Virtual Rare Orphan Disea..
BU
03/18Arcturus Therapeutics Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
BU
03/14Arcturus Therapeutics to Participate in the Barclays Global Healthcare Conference
BU
03/01ARCTURUS THERAPEUTICS HOLDINGS INC. Management's Discussion and Analysis of Financial ..
AQ
02/28ARCTURUS THERAPEUTICS : Announces Fourth Quarter and Full Year 2021 Financial Update and P..
PU
02/28ARCTURUS THERAPEUTICS : Q4 Earnings Snapshot
AQ
02/28Arcturus Therapeutics Announces Fourth Quarter and Full Year 2021 Financial Update and ..
BU
02/21Arcturus Therapeutics Reports Inducement Grant Under Nasdaq Listing Rule 5635(4)
AQ
02/18Arcturus Therapeutics Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
BU
02/17ARCTURUS THERAPEUTICS HOLDINGS INC. : Other Events, Financial Statements and Exhibits (for..
AQ
02/16Arcturus Therapeutics to Report Fourth Quarter and Year-End 2021 Financial Results and ..
BU
02/11ARCTURUS THERAPEUTICS HOLDINGS INC. : Change in Directors or Principal Officers (form 8-K)
AQ
02/08Arcturus Therapeutics to Participate in the SVB Leerink 11th Annual Global Healthcare C..
BU
01/25Arcturus Therapeutics Reports New Data Demonstrating Neutralizing Antibody Immune Respo..
BU
01/24Arcturus Therapeutics Reports Inducement Grant Under Nasdaq Listing Rule 5635(4)
AQ
01/24Arcturus Therapeutics Updates Data from ARCT-154 and ARCT-165 Booster Clinical Trial De..
BU
01/21Arcturus Therapeutics Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
BU
01/11ARCTURUS THERAPEUTICS HOLDINGS INC. : Regulation FD Disclosure (form 8-K)
AQ
2021Arcturus Therapeutics Reports Inducement Grant Under Nasdaq Listing Rule 5635(4)
AQ
2021Arcturus Therapeutics Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
BU
2021Arcturus Therapeutics Reports New Data and Provides Additional Updates from ARCT-154 an..
BU
2021ARCTURUS THERAPEUTICS : Appoints Jing Marantz, M.D., Ph.D., M.B.A. to its Board of Directo..
PU
2021ARCTURUS THERAPEUTICS HOLDINGS INC. : Change in Directors or Principal Officers, Amendment..
AQ
2021Arcturus Therapeutics Appoints Jing Marantz, M.D., Ph.D., M.B.A. to its Board of Direct..
BU
2021Arcturus Therapeutics to Participate in Piper Sandler 33rd Annual Healthcare Conference
BU
2021Arcturus Therapeutics Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
BU
2021ARCTURUS THERAPEUTICS HOLDINGS INC. : Other Events, Financial Statements and Exhibits (for..
AQ
2021ARCTURUS THERAPEUTICS HOLDINGS INC. Management's Discussion and Analysis of Financial ..
AQ
2021Arcturus Therapeutics Announces Third Quarter 2021 Financial Update and Pipeline Progre..
PU
2021ARCTURUS THERAPEUTICS : Q3 Earnings Snapshot
AQ
2021Arcturus Therapeutics Announces Third Quarter 2021 Financial Update and Pipeline Progre..
BU
2021ARCTURUS THERAPEUTICS HOLDINGS INC. : Entry into a Material Definitive Agreement, Financia..
AQ
2021ARCTURUS THERAPEUTICS : to Report Third Quarter 2021 Financial Results and Provide Corpora..
BU
2021ARCTURUS THERAPEUTICS : Announces Leadership Appointments
BU
2021ARCTURUS THERAPEUTICS : Reports Inducement Grant Under Nasdaq Listing Rule 5635(4)
AQ
2021ARCTURUS THERAPEUTICS : Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
BU
2021ARCTURUS THERAPEUTICS : Announces Approval from Vietnam Ministry of Health to Proceed into..
AQ
2021ARCTURUS THERAPEUTICS : Announces Approval from Vietnam Ministry of Health to Proceed into..
BU
2021Combined Market Cap of Top Five mRNA Companies hit $265B, a Fivefold Increase in a Year
AQ
2021ARCTURUS THERAPEUTICS HOLDINGS INC. : Entry into a Material Definitive Agreement, Creation..
AQ
2021ARCTURUS THERAPEUTICS : Announces Approval from Vietnam Ministry of Health to Proceed into..
AQ
2021ARCTURUS THERAPEUTICS : Announces Meeting with President of Vietnam and CEO of Vingroup to..
BU
2021ARCTURUS THERAPEUTICS : Announces Approval from Vietnam Ministry of Health to Proceed into..
BU
2021ARCTURUS THERAPEUTICS : to Participate in Citi's 16th Annual BioPharma Virtual Conference ..
BU
2021ARCTURUS THERAPEUTICS : to Present at Upcoming Investor and Scientific Conferences
BU
2021ARCTURUS THERAPEUTICS HOLDINGS INC. : Termination of a Material Definitive Agreement, Chan..
AQ
2021ARCTURUS THERAPEUTICS : Late Filing Notice (SEC Filing - NT 10-Q)
PU
2021ARCTURUS THERAPEUTICS : Management's Discussion and Analysis of Financial Condition and Re..
AQ
2021ARCTURUS THERAPEUTICS : Q2 Earnings Snapshot
AQ
2021ARCTURUS THERAPEUTICS HOLDINGS INC. : Results of Operations and Financial Condition, Regul..
AQ
2021ARCTURUS THERAPEUTICS : Announces Second Quarter 2021 Financial Results and mRNA Vaccine a..
BU
2021ARCTURUS THERAPEUTICS HOLDINGS INC. : Entry into a Material Definitive Agreement (form 8-K..
AQ
2021ARCTURUS THERAPEUTICS : Announces Approval of Singapore Clinical Trial Application to Adva..
AQ
2021ARCTURUS THERAPEUTICS : Announces Approval of a Clinical Trial Application to Advance ARCT..
AQ
2021ARCTURUS THERAPEUTICS : Collaborates with Vingroup to Establish Manufacturing Facility in ..
AQ
2021ARCTURUS THERAPEUTICS : Announces Approval of Singapore Clinical Trial Application to Adva..
BU
2021ARCTURUS THERAPEUTICS : Announces Approval of a Clinical Trial Application to Advance ARCT..
BU
2021ARCTURUS THERAPEUTICS : Collaborates with Vingroup to Establish Manufacturing Facility in ..
BU
2021ARCTURUS THERAPEUTICS : Announces Regulatory Approval to Proceed with Phase 2 Study of ARC..
AQ
2021ARCTURUS THERAPEUTICS : Announces Regulatory Approval to Proceed with Phase 2 Study of ARC..
BU
2021ARCTURUS THERAPEUTICS : to Report Second Quarter 2021 Financial Results and Provide Corpor..
BU
2021ARCTURUS THERAPEUTICS : to Present at Upcoming Investor and Scientific Conferences
BU
2021ARCTURUS THERAPEUTICS HOLDINGS INC. : Submission of Matters to a Vote of Security Holders ..
AQ
2021ARCTURUS THERAPEUTICS : to Present at Upcoming Investor and Scientific Conferences
BU
2021PRIMORDIAL GENETICS : Grants Arcturus Therapeutics Exclusive License of an RNA Polymerase ..
PR
1  2  3Next
Upcoming event on ARCTURUS THERAPEUTICS HOLDINGS INC.